AA
PFE icon

Auxano Advisors’s Pfizer PFE Stock Holding History

Auxano Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$292K Buy
10,382
+120
+1% +$3.19K 0.06% 159
2025
Q4 		$256K Sell
10,262
-52
-0.5% -$1.31K 0.05% 166
2025
Q3 		$263K Sell
10,314
-12,409
-55% -$306K 0.06% 149
2025
Q2 		$551K Sell
22,723
-761
-3% -$17.7K 0.13% 91
2025
Q1 		$595K Sell
23,484
-943
-4% -$24.7K 0.16% 86
2024
Q4 		$648K Buy
24,427
+3,553
+17% +$96.4K 0.16% 82
2024
Q3 		$604K Buy
20,874
+702
+3% +$20.5K 0.16% 93
2024
Q2 		$564K Sell
20,172
-135
-0.7% -$3.72K 0.16% 90
2024
Q1 		$564K Buy
+20,307
New +$563K 0.16% 89
2023
Q4 		– Sell
-7,636
Closed -$253K – 133
2023
Q3 		$253K Buy
7,636
+268
+4% +$9.48K 0.1% 87
2023
Q2 		$301K Hold
7,368
– – 0.12% 82
2023
Q1 		$301K Buy
7,368
+643
+10% +$27.8K 0.12% 82
2022
Q4 		$345K Buy
6,725
+8
+0.1% +$384 0.16% 73
2022
Q3 		$294K Buy
6,717
+1,883
+39% +$91.5K 0.14% 75
2022
Q2 		$253K Buy
4,834
+321
+7% +$16.4K 0.13% 67
2022
Q1 		$234K Buy
+4,513
New +$234K 0.1% 73

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Auxano Advisors's PFE Position: Q1 2026 in Review

Auxano Advisors increased its Pfizer (PFE) stake by 1.2% in Q1 2026, buying an estimated $3.19K and bringing the position to 10,382 shares worth $292K. The position accounts for 0.06% of the portfolio, ranked #159.

Auxano Advisors first reported a position in PFE in Q1 2022 and has held it in 16 quarters since. The position peaked at $648K in Q4 2024. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Auxano Advisors held 10,382 shares of Pfizer worth $292K as of Q1 2026.
  • Auxano Advisors bought 120 Pfizer shares in Q1 2026, an estimated $3.19K.
  • Pfizer made up 0.06% of Auxano Advisors's portfolio in Q1 2026, its #159 holding.
  • Auxano Advisors first reported a position in Pfizer in Q1 2022 and has held it in 16 quarters since.
  • Auxano Advisors's Pfizer position peaked at $648K in Q4 2024.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Auxano Advisors's 13F filing for Q1 2026, filed 4 May 2026.